Rituximab Therapy in Neuromyelitis Optica: Moving Toward a Personalized Medicine Approach

JAMA Neurol. 2015 Sep;72(9):974-7. doi: 10.1001/jamaneurol.2015.1421.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Female
  • Humans
  • Immunologic Factors / therapeutic use*
  • Male
  • Neuromyelitis Optica / drug therapy*
  • Neuromyelitis Optica / genetics*
  • Polymorphism, Single Nucleotide / genetics*
  • Receptors, IgG / genetics*
  • Rituximab / therapeutic use*

Substances

  • Immunologic Factors
  • Receptors, IgG
  • Rituximab